Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2014

Open Access 01-12-2014 | Meeting abstract

EHMTI-0293. Comparison between celecoxib and prednisolone in bridge stage therapy following medication overuse headache: double blind randomized clinical trial

Authors: M Togha, SMH Paknejad, E Taghvaei, T Ramim, S Razeghi jahromi

Published in: The Journal of Headache and Pain | Special Issue 1/2014

Login to get access

Excerpt

Many patients with chronic or frequent headaches overuse the analgestic or anti-migraine drugs. Medication overuse headache (MOH) is a common severe headache. The basis of treatment of MOH is discontinuation of the offending drugs. However, cessation of drug consumption could lead to severe disabling headache. Corticosteroids are the most popular drugs for bridge phase of treatment. However corticosteroids might cause different side effects. Celecoxib is a Cox 2 inhibitor drug with analgesic and anti-inflammatory properties, assumed to be a good alternative for steroids. …
Metadata
Title
EHMTI-0293. Comparison between celecoxib and prednisolone in bridge stage therapy following medication overuse headache: double blind randomized clinical trial
Authors
M Togha
SMH Paknejad
E Taghvaei
T Ramim
S Razeghi jahromi
Publication date
01-12-2014
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-C54

Other articles of this Special Issue 1/2014

The Journal of Headache and Pain 1/2014 Go to the issue

Meeting abstract

EHMTI-0194. The impact of dizziness in tertiary care migraine patients

Meeting abstract

EHMTI-0340. Distance treatment programs for individuals with complex chronic headaches living far from the hospital: the Canadian experience

Meeting abstract

EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase

Meeting abstract

EHMTI-0184. Ictal adiponectin levels are modulated by pain severity and treatment response in episodic migraineurs

Meeting abstract

EHMTI-0316. Exam findings predict outcome of C1 block for migraine treatment

Meeting abstract

EHMTI-0080. How migraine is affected by therapies for multiple sclerosis